Patterns of Language Impairment in Early Amyotrophic Lateral Sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 3, 2020
- Accepted October 7, 2020
- First Published November 2, 2020.
Article Versions
- Previous version (November 2, 2020 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Marta Pinto-Grau, PhD,
- Bronagh Donohoe, MSc,
- Sarah O'Connor, MSc,
- Lisa Murphy, MSc,
- Emmet Costello, BSc,
- Mark Heverin, MSc,
- Alice Vajda, PhD,
- Orla Hardiman, MD, FRCPI, FTCD, MRIA and
- Niall Pender, PhD
- Marta Pinto-Grau, PhD,
- Bronagh Donohoe, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sarah O'Connor, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lisa Murphy, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Emmet Costello, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)Science Foundation Ireland (grant number 205532)
NONE
NONE
NONE
NONE
NONE
NONE
- Mark Heverin, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alice Vajda, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Orla Hardiman, MD, FRCPI, FTCD, MRIA and
Served on ad hoc advisory boards for Novartis (2010) and Biogen Idec (2010,201,2013,2014)Allergan (2010), Cytokinetics (2012, 2014, 2016, 2017), Treeway (2017,2018) Wave (2017) Serve on NINDS CDE Team for ALS/MND
NONE
Travel grants provided by Novartis, Biogen Idec and Merck to attend international neurology meetings.
Editor in Chief Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Editorial Board Journal of Neurology Neurosurgery & Psychiatry
Patents Patent Title: Treatment of Central Nervous System Injury Inventors (RCSI): Orla Hardiman Jochen Prehn ; Matt Greenway Dairin Kieran Application No.: PCT/IE2006/000091 Country: International Status: Pending Patent Title: Treatment of Neurodegenerative Disease Inventors (RCSI): Orla Hardiman ;Matt Greenway Application No.: WO2005IE00131 Country: International Status: Pending Publication No: WO2006054277
NONE
NONE
I consult for Biogen Idec, Cytokinetics
NONE
NONE
NONE
NONE
NONE
NONE
The research leading to these results has received funding Health Research Board Clinician Scientist Award Program Science Foundation Ireland 15/SPP/3244 Science Foundation Ireland 16/ERCD/3854 ALSA Research Motor Neuron Motor Neuron Disease Association (UK)
NONE
NONE
NONE
NONE
NONE
NONE
- Niall Pender, PhD
NONE
NONE
Novartis, speaker honorarium.
International Journal of Neuroscience, Associate Editor 2017-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Academic Unit of Neurology (MP-G, BD, SO, LM, EC, MH, AV, OH, NP), Trinity Biomedical Sciences Institute, Trinity College Dublin; and Department of Psychology (MP-G, BD, SO, LM, EC, NP), Beaumont Hospital, Dublin, Ireland.
- Correspondence
Dr. Pinto-Grau pintogrm{at}tcd.ie
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.